Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - HERON THERAPEUTICS, INC. /DE/ | d530534dex321.htm |
| EX-31.2 - EX-31.2 - HERON THERAPEUTICS, INC. /DE/ | d530534dex312.htm |
| EX-31.1 - EX-31.1 - HERON THERAPEUTICS, INC. /DE/ | d530534dex311.htm |
| 10-K - FORM 10-K - HERON THERAPEUTICS, INC. /DE/ | d530534d10k.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-219172, 333-190550, 333-195928, 333-198862 and 333-212784) and Form S-8 (Nos. 333-219830, 333-35151, 333-90428, 333-118546, 333-127574, 333-137954, 333-148660, 333-162610, 333-167515, 333-176365, 333-176366, 333-190549, 333-198853, 333-202588, 333-206165 and 333-214503) of Heron Therapeutics, Inc. of our reports dated February 27, 2018 relating to the consolidated financial statements and the effectiveness of Heron Therapeutics, Inc.’s internal control over financial reporting, which appear in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
February 27, 2018